This subdirectory contains:\
Figure1: Boxplot to examine age distribution between sacubitril/valsartan and enalapril groups. \
Figure2: Count plot to check sex distribution among sacubitril/valsartan and enalapril groups. \
Figure3: Count plot illustrating race distribution among sacubitril/valsartan and enalapril groups. \
Figure4: Count plot illustrating ethnicity distribution among sacubitril/valsartan and enalapril groups. \
Figure5: Boxplot displaying BMI distribution among sacubitril/valsartan and enalapril groups. \
Figure6: Count plot to assess smoking history distribution among sacubitril/valsartan and enalapril groups. \
Figure7: Count plot to examine the previous Use of ACE inhibitor or ARB distribution among sacubitril/valsartan and enalapril groups. \
Figure8: Boxplot to check left ventricular ejection fraction (%) distribution among sacubitril/valsartan and enalapril groups. \
Figure9: Count plot to check chronic renal insufficiency among sacubitril/valsartan and enalapril groups. \
Figure10: Boxplot illustrating pre-treatment NT-proBNP (pg/mL) concentration distribution among sacubitril/valsartan and enalapril groups. \
Figure11: Boxplot illustrating pre-treatment BNP (pg/mL) concentration distribution among sacubitril/valsartan and enalapril groups. \
Figure12: Boxplot and strip plot to explore the relation between smoking history and left ventricular ejection fraction (%) among intervention groups. \
Figure13: Line plot to illustrate NT-proBNP concentration over time among intervention groups. \
Figure14: Heatmap to visualize NT-proBNP concentration at Week 8 cross different age among intervention groups. \
Figure15: violin plot to compare symptomatic hypotension as side effect among sacubitril/valsartan and enalapril groups. \
Figure16: Count plot to compare hyperkalemia as side effect among sacubitril/valsartan and enalapril groups. \
Figure17: Count plot to compare death among sacubitril/valsartan and enalapril groups. 
